Medicure enters License, Manufacture and Supply Agreement with Reliance Life Sciences

Oct 5, 2020

Medicure announces it has entered a License, Manufacture and Supply Agreement with Reliance Life Sciences for a cardiovascular biosimilar product for EU, US and Canada. Medicure is responsible for the regulatory approval process for that product.

Print Page Mail Article